(Q37999089)

26 August 2017

title

The emerging role of plasma lipidomics in cardiovascular drug discovery (English)

1 reference

26 August 2017

1 reference

1 reference

Rishi Puri

1

1 reference

26 August 2017

MyNgan Duong

2

1 reference

26 August 2017

Kiyoko Uno

3

1 reference

26 August 2017

Yu Kataoka

4

1 reference

26 August 2017

Stephen J Nicholls

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

12 December 2011

1 reference

Expert Opinion on Drug Discovery

26 August 2017

published in

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

63-72

1 reference

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Effect of ACAT inhibition on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Effect of torcetrapib on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Mass spectrometry: from proteomics to metabolomics and lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Lipidomics at the interface of structure and function in systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Electrospray ionization for mass spectrometry of large biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

The emerging field of lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Applications of mass spectrometry to lipids and membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Solvent-free matrix dry-coating for MALDI imaging of phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Solid-state nuclear magnetic resonance investigation of protein and polypeptide structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Novel NMR tools to study structure and dynamics of biomembranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Imaging mass spectrometry: principles and potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Nanoparticle-assisted laser desorption/ionization based mass imaging with cellular resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Visualization of the cell-selective distribution of PUFA-containing phosphatidylcholines in mouse brain by imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Tandem Mass Spectrometric Methods for Phospholipid Analysis from Brain Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Cholesterol and mortality. 30 years of follow-up from the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Lipidomics as a tool for the study of lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Genetic determinants of circulating sphingolipid concentrations in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Plasma sphingomyelin level as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Approach to the patient who is intolerant of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Weighing the benefits of high-dose simvastatin against the risk of myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Lipidomics-based safety biomarkers for lipid-lowering treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

The plasma lipidomic signature of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Plasma lipidomic analysis of stable and unstable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.644041

10.1517/17460441.2012.644041

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference